Heron Therapeutics (HRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,580 | -110,559 | -182,024 | -220,683 | -227,278 |
| Depreciation Amortization | 1,310 | 1,499 | 2,355 | 4,257 | 4,401 |
| Accounts receivable | -18,744 | -8,088 | -16,550 | 6,351 | -1,971 |
| Accounts payable and accrued liabilities | 8,469 | 15 | -578 | 3,278 | -2,233 |
| Other Working Capital | -27,603 | 16,790 | -10,506 | -35,079 | -13,008 |
| Other Operating Activity | 27,619 | 41,554 | 60,391 | 38,522 | 55,269 |
| Operating Cash Flow | $-22,529 | $-58,789 | $-146,912 | $-203,354 | $-184,820 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 20,393 | 19,527 | -1,726 | 35,719 | 215,768 |
| PPE Investments | -1,679 | -1,532 | -1,598 | -2,990 | -6,813 |
| Investing Cash Flow | $18,714 | $17,995 | $-3,324 | $32,729 | $208,955 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 24,350 | N/A | 148,963 | 26 |
| Common Stock Issued | 940 | 29,756 | 75,059 | 7,065 | 9,076 |
| Other Financing Activity | 0 | 1 | 0 | 0 | 3 |
| Financing Cash Flow | $940 | $54,107 | $75,059 | $156,028 | $9,105 |
| Beginning Cash Position | 28,677 | 15,364 | 90,541 | 105,138 | 71,898 |
| End Cash Position | 25,802 | 28,677 | 15,364 | 90,541 | 105,138 |
| Net Cash Flow | $-2,875 | $13,313 | $-75,177 | $-14,597 | $33,240 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,529 | -58,789 | -146,912 | -203,354 | -184,820 |
| Capital Expenditure | -1,706 | -1,545 | -1,825 | -3,022 | -6,813 |
| Free Cash Flow | -24,235 | -60,334 | -148,737 | -206,376 | -191,633 |